002675.SZ
Yantai Dongcheng Biochemicals Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 12.77
−2.07%Price chart
Aug 21Aug 26Aug 31Sep 3Sep 8Sep 11Sep 16Sep 21
Key dataSep 21, 2026
OpenCNY 12.47
From 52W high−22.18%
Volume7.37M
Market capCNY 10.53B
P/E (TTM)53.8x
P/S (TTM)3.8x
Div yield0.65%
Key dataSep 21, 2026
Open
CNY 12.47
From 52W high
−22.18%
Volume
7.37M
Market cap
CNY 10.53B
ValuationView details →
P/E (Fwd)
27.1x
EV/EBITDA
27.4x
P/E (TTM)
53.8x
RSI (14)
39.4
MomentumView details →
1D Return
−2.07%
YTD Return
−9.24%
Similar companies
Latest newsMore news →
Yantai Dongcheng North Pharmaceutical, a wholly-owned subsidiary of Dongcheng Pharmaceutical, received acceptance of its marketing authorization application for Bemiparin Sodium Injection from China's National Medical Products Administration on September 9, 2026.12d agoDongcheng Pharmaceutical announced that as of August 31, 2026, it had repurchased 7.3995 million shares (0.90% of total shares) for a total of 100 million yuan under its ongoing buyback program.19d agoDongcheng Pharmaceutical's wholly-owned subsidiary Andike signed equity transfer agreements to acquire 100% of Kunming Cyclotron and 100% of Sichuan Cyclotron for RMB 40.2 million and RMB 40 million respectively, and to sell its 45% stake in Guangdong Cyclotron for RMB 121 million.28d ago